Activity indicators for the evaluation of applications for reimbursement and prior evaluation of medicinal products

**Number of requests for co-financing submitted** \- Number of contribution assessment processes submitted by TAIM/Applicant; **Number of Prior Assessment Requests submitted** \- Number of procedures for the evaluation of medicinal products for use in SNS Hospitals submitted by TAIM/Applicant; **Number of Compensation Requests completed** \- Number of Compensation Evaluation Processes completed, regardless of the decision; **Number of Prior Assessment Requests completed** \- Number of procedures for the evaluation of medicinal products for use in SNS Hospitals completed, regardless of the decision; **Average time of completion of approved and rejected generic and biosimilar drug evaluation processes** \- Average time, in calendar days, from the date of submission to the decision date by the CD, of processes classified as generic and biosimilar, submitted after 07-09-2017. Excludes Validation Time (established in Article 5 of Ordinance No. 195-A/2015 of 30 June) and Company Time. **Average time of completion of procedures for the evaluation of new presentations of approved and rejected non-generic medicinal products** \- Average time, in calendar days, which elapses from the date of submission to the decision date by the CD/SES, of processes classified as new presentations of non-generic medicinal products submitted after 07-09-2017. Excludes Validation Time (established in Article 5 of Ordinance No. 195-A/2015 of 30 June) and Company Time. **Average time of completion of evaluation procedures for new active substances or new approved and rejected indications** \- Average time, in calendar days, from the date of submission to the decision date by the CD/SES, of dossiers classified as new active substances or new indications submitted after 07-09-2017. Excludes Validation Time (established in Article 5 of Ordinance No. 195-A/2015 of 30 June) and Company Time. **Percentage of processes for the evaluation of applications for participation and prior evaluation approved and rejected within the period** \- Percentage of pre-approved and rejected participation and evaluation processes within the period established in the legislation in force, in relation to the number of pre-approved and rejected participation and evaluation processes. Only cases approved and rejected with submission date after 07-09-2017 are considered.